Key result
SABR-VMAT with DIBH stabilizes recurrent left atrial liposarcoma without acute toxicity or valve dysfunction.
Why the study?
Primary cardiac sarcomas are extremely rare and aggressive with limited treatment options, and local recurrence is frequent even after apparently complete surgical resection.
Does stereotactic body radiotherapy delivered by volumetric modulated arc therapy under deep inspiration breath-hold provide a feasible and safe local treatment option in a patient with recurrent cardiac sarcoma?
Case Report (n=1)
Does stereotactic body radiotherapy delivered by volumetric modulated arc therapy under deep inspiration breath-hold provide a feasible and safe local treatment option in a patient with recurrent cardiac sarcoma?
This case report demonstrates the short-term feasibility and safety of SABR-VMAT with deep inspiration breath-hold for treating recurrent left atrial dedifferentiated liposarcoma when surgery or MR-guided radiotherapy are unavailable.
Answers are grounded in this paper and cite their sources.
SABR may offer salvage for recurrent cardiac sarcoma; leaves open efficacy, safety, and role in prospective trials.
Primary cardiac sarcomas are extremely rare and aggressive cancers with a generally poor prognosis and limited treatment options. Surgery remains the mainstay of management, but local recurrence is frequent even after apparently complete resection. We describe the case of a 56-year-old woman with a recurrent dedifferentiated liposarcoma of the left atrium following mitral valve replacement. The recurrence was treated with stereotactic body radiotherapy (SABR) delivered by volumetric modulated arc therapy (VMAT) under deep inspiration breath-hold (DIBH). A total dose of 32.5 Gy in five fractions was administered. The treatment was well tolerated, with no acute cardiac or pulmonary toxicity and preserved valve function. Two months after treatment, lesion remains stable and no altered cardiac function. This case supports the feasibility and safety of SABR-VMAT with DIBH for recurrent cardiac sarcoma, offering an effective local option when surgery or MR-guided RT are not available.
No takes yet. Share an insight, caveat, or question.
Sanchez et al. (2026) conducted a case report in Recurrent dedifferentiated liposarcoma of the left atrium (n=1). Stereotactic body radiotherapy (SABR) delivered by volumetric modulated arc therapy (VMAT) under deep inspiration breath-hold (DIBH) was evaluated on Local tumor control, cardiac/pulmonary toxicity, and valve function. SABR-VMAT with DIBH for recurrent left atrial liposarcoma achieved lesion stability and preserved cardiac/valve function with no acute toxicity at 2 months.
Synapse has enriched 10 related papers. Consider them for comparative context: